×
About 8,425 results

ALLMedicine™ Lymphadenopathy Center

Research & Reviews  2,901 results

Patients presenting high fever with lymphadenopathy after COVID-19 vaccination were dia...
https://doi.org/10.1080/23744235.2021.2010801
Infectious Diseases (London, England); Baek DW, Hwang S et. al.

Dec 3rd, 2021 - The coronavirus disease 2019 (COVID-19) pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is still continuing worldwide. Currently, two mRNA-based vaccines and two DNA vaccines using an adenovirus vector are repre...

Para-aortic lymphadenopathy associated with adult COVID-19 multisystem inflammatory syn...
https://doi.org/10.1136/bcr-2021-246884
BMJ Case Reports; Carvalho V, Damasco PH et. al.

Dec 3rd, 2021 - A 21-year-old woman arrived at the emergency department with dyspnoea, arterial hypotension and abdominal pain after 5 days with a influenza-like syndrome. SARS-CoV-2 was detected by reverse transcription PCR in a nasopharyngeal swab specimen. CT ...

A Case of Nasal Cavity and Laryngeal Involvement of Rosai-Dorfman Disease.
https://doi.org/10.1177/01455613211054632
Ear, Nose, & Throat Journal; Lee C, Choi N et. al.

Nov 30th, 2021 - Rosai-Dorfman disease (RDD) is a rare non-malignant disorder, characterized by painless multiple cervical lymphadenopathy, fever, and elevated inflammatory markers. Its diagnosis is difficult due to its rare incidence and various clinical presenta...

Diagnosis and Management of Occult Cervical Tuberculous Lymphadenopathy.
https://doi.org/10.1177/01455613211043692
Ear, Nose, & Throat Journal; Li WX, Zhu Y et. al.

Nov 30th, 2021 - Objective: Some cervical tuberculous lymphadenopathy (CTL) presents no evidence of tuberculosis (TB), even after thorough examination of a fine-needle aspiration (FNA) specimen. After the examination of excisional specimens, when the polymerase ch...

COVID-19 vaccine-related axillary lymphadenopathy in breast cancer patients: Case serie...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8547943
Seminars in Oncology; Lim J, Lee SA et. al.

Nov 28th, 2021 - Lymphadenopathy (LAP) after COVID-19 vaccination in patients with a diagnosis of cancer has been challenging. We analyzed imaging and clinical features from early cases of axillary LAP in six COVID-19 vaccine recipients with a history of breast ca...

see more →

Guidelines  4 results

ACR Appropriateness Criteria® Pretreatment Evaluation and Follow-Up of Endometrial Cancer.
https://doi.org/10.1016/j.jacr.2020.09.001
Journal of the American College of Radiology : JACR; , Reinhold C et. al.

Nov 7th, 2020 - To date, there is little consensus on the role of pelvic imaging in assessing local disease extent during initial staging in patients with endometrial carcinoma, with practices differing widely across centers. However, when pretreatment assessment...

ACOG Committee Opinion No. 752 Summary: Prenatal and Perinatal Human Immunodeficiency V...
https://doi.org/10.1097/AOG.0000000000002829
Obstetrics and Gynecology;

Aug 23rd, 2018 - Given the enormous advances in the prevention of perinatal transmission of human immunodeficiency virus (HIV), it is clear that early identification and treatment of all pregnant women with HIV is the best way to prevent neonatal infection and als...

Indications, results, and clinical impact of endoscopic ultrasound (EUS)-guided samplin...
https://doi.org/10.1055/s-0043-109021
Endoscopy Dumonceau JM, Deprez PH et. al.

May 17th, 2017 - For pancreatic solid lesions, ESGE recommends performing endoscopic ultrasound (EUS)-guided sampling as first-line procedure when a pathological diagnosis is required. Alternatively, percutaneous sampling may be considered in metastatic disease.St...

Revised diagnostic criteria and classification for the autoimmune lymphoproliferative s...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2953894
Blood Oliveira JB, Bleesing JJ et. al.

Jun 12th, 2010 - Lymphadenopathy in children for which no infectious or malignant cause can be ascertained constitutes a challenging diagnostic dilemma. Autoimmune lymphoproliferative syndrome (ALPS) is a human genetic disorder of lymphocyte apoptosis resulting in...

see more →

Drugs  72 results see all →

Clinicaltrials.gov  58 results

Phase I Trial of the Combination of Zidovudine and Recombinant Interleukin-2 in Patients With Persistent Generalized Lymphadenopathy
https://clinicaltrials.gov/ct2/show/NCT00000728

Nov 3rd, 2021 - AZT has been shown to be effective in HIV-related disease. IL-2 has been shown to increase immune responses and correct immune problems caused by HIV in the test tube. IL-2 has also been effective in treating Kaposi's sarcoma in a number of patien...

Natural History, Genetics, and Pathophysiology of Systemic Juvenile Idiopathic Arthritis, Adult-Onset Still's Disease, and Related Conditions
https://clinicaltrials.gov/ct2/show/NCT03510442

Oct 29th, 2021 - The purpose of this protocol is to study the natural history, genetics and pathophysiology of systemic juvenile idiopathic arthritis (sJIA), adult-onset Still s disease (AOSD) and related inflammatory conditions. One of seven subtypes of juvenile ...

History of the KSHV Inflammatory Cytokine Syndrome (KICS)
https://clinicaltrials.gov/ct2/show/NCT01419561

Oct 4th, 2021 - BACKGROUND: KSHV inflammatory cytokine syndrome (KICS) is a newly recognized syndrome caused by Kaposi sarcoma-associated herpesvirus (KSHV). It is characterized by severe inflammatory symptoms including fevers, wasting, cytopenias, hypoalbuminemi...

Chlorhexidine Mouthrinse Before EBUS-TBNA
https://clinicaltrials.gov/ct2/show/NCT04718922

Sep 23rd, 2021 - EBUS-TBNA using the convex probe is a standard of care for the assessment of mediastinal and hilar lymphadenopathy. Although EBUS-TBNA is a minimally invasive procedure, rare but serious infectious complications such as pneumonia, lung abscess, em...

A Study to Evaluate the Efficacy and Safety of Obinutuzumab, Ibrutinib, and Venetoclax in Patients With Richter's Syndrome;
https://clinicaltrials.gov/ct2/show/NCT04939363

Sep 21st, 2021 - Richter's syndrome (RS) is a life-threatening complication of chronic lymphocytic leukemia (CLL). It is associated with a switch in histopathology and biology, generally with a transformation of the original CLL clone to diffuse large B-cell lymph...

see more →

News  335 results

Red Morbilliform Rash and Facial Involvement? Think DRESS
https://www.medscape.com/viewarticle/962373

Nov 5th, 2021 - LOS ANGELES ― Should severe adverse drug reactions that occur after initiation of a new medication be termed "drug reaction with eosinophilia and systemic symptoms" (DRESS), or something else? Dr Misha Rosenbach According to Misha Rosenbach, MD, o...

FDA Staff 'Meh' on Moderna Booster
https://www.medpagetoday.com/infectiousdisease/covid19vaccine/94996

Oct 12th, 2021 - Data from an ongoing clinical trial found that a booster dose of Moderna's COVID-19 vaccine produced an immune response with no serious safety concerns, FDA staff said in briefing documents released on Tuesday. However, similar to the Pfizer COVID...

Novel Radium-223 Combinations on the Horizon in Bone-Metastatic CRPC
https://www.onclive.com/view/novel-radium-223-combinations-on-the-horizon-in-bone-metastatic-crpc

Oct 6th, 2021 - Daniel P. Petrylak, MD Novel combination approaches are currently under exploration that hope to capitalize on the varying mechanisms of action for each newly approved agent for men with metastatic castration-resistant prostate cancer (mCRPC), ac...

Radium-223 Focus of Several Ongoing Combination Studies in mCRPC
https://www.onclive.com/view/radium-223-focus-of-several-ongoing-combination-studies-in-mcrpc

Oct 6th, 2021 - A. Oliver Sartor, MD A randomized study is underway to determine if the combination of sipuleucel-T (Provenge) and radium-223 (Xofigo) may improve outcomes in patients with metastatic castration-resistant prostate cancer (CRPC), according to a po...

Talking Tumors: Turning to Liquid Biopsies and Immunotherapy in Lung Cancer
https://www.onclive.com/view/talking-tumors-turning-to-liquid-biopsies-and-immunotherapy-in-lung-cancer

Oct 6th, 2021 - We recently traveled to Austin, Texas, for a State of the Science Summit™ on Lung Cancer. Immunotherapy, whether alone or in combination with chemotherapy, has become a frontline standard of care in advanced non—small cell lung cancer. While PD-L1...

see more →